Our MyTherapy software platform is the Operating System for Digital Therapeutics (DTx). It enables our partners to focus on designing effective DTx algorithms and interventions and to have their DTx benefit from impact proven in studies and with millions of patients.
Modular and configurable platform services and an agile approach to QM and RA reduce time-to-market and enable rapid global deployment under MDR, FDA, and beyond. Our team of behavioral scientists, designers, medical writers, and data scientists supports intervention design, patient recruiting, and clinical evaluation as needed.
Building powerful applications is just so much easier with an operating system in place. Innovators from pharma, medtech and academia leverage the MyTherapy platform as operating system for their DTx, so they can focus on developing its therapeutic/diagnostic nucleus. While maintaining ownership of their IP, they benefit from configurable platform elements, built-in regulatory compliance and the outstanding engagement of the MyTherapy app.
With MyTherapy, you can run your DTx in an environment proven with millions of users, 4.8 out of 5 stars average rating, and agile improvements applied through more than 300 releases. If engagement matters for your DTx, building on MyTherapy saves you years of agile refinements to your user experience.
Any DTx needs a lot of underlying basics: Robust notifications, connectivity with Google Fit and Apple Health, a chatbot interface, and many more. You can build and maintain all of these yourself. Or you can plug into MyTherapy, consume them as a service, and focus on interventions that deliver improved health outcomes.
Being medical device software, DTx requires quality management as per ISO 13485. To avoid compromising on agility, we take a sandbox approach, whereby the medical device runs as a dedicated module in a validated environment. All non-medical device features run outside this sandbox and benefit from agile refinements.